168 related articles for article (PubMed ID: 27494870)
1. Novel antibody probes for the characterization of endosialin/TEM-1.
O'Shannessy DJ; Smith MF; Somers EB; Jackson SM; Albone E; Tomkowicz B; Cheng X; Park Y; Fernando D; Milinichik A; Kline B; Fulton R; Oberoi P; Nicolaides NC
Oncotarget; 2016 Oct; 7(43):69420-69435. PubMed ID: 27494870
[TBL] [Abstract][Full Text] [Related]
2. Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.
Rybinski K; Imtiyaz HZ; Mittica B; Drozdowski B; Fulmer J; Furuuchi K; Fernando S; Henry M; Chao Q; Kline B; Albone E; Wustner J; Lin J; Nicolaides NC; Grasso L; Zhou Y
Oncotarget; 2015 Sep; 6(28):25429-40. PubMed ID: 26327620
[TBL] [Abstract][Full Text] [Related]
3. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
[TBL] [Abstract][Full Text] [Related]
4. Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature.
Kontseková S; Ohradanova Repic A; Polčicová K; Tuomaala P; Pastorek J; Pastoreková S; Parkkila S; Baráthová M
Int J Oncol; 2012 Oct; 41(4):1365-72. PubMed ID: 22824847
[TBL] [Abstract][Full Text] [Related]
5. A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors.
Diaz LA; Coughlin CM; Weil SC; Fishel J; Gounder MM; Lawrence S; Azad N; O'Shannessy DJ; Grasso L; Wustner J; Ebel W; Carvajal RD
Clin Cancer Res; 2015 Mar; 21(6):1281-8. PubMed ID: 25398449
[TBL] [Abstract][Full Text] [Related]
6. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA
Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839
[TBL] [Abstract][Full Text] [Related]
7. Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications.
Lange SE; Zheleznyak A; Studer M; O'Shannessy DJ; Lapi SE; Van Tine BA
Oncotarget; 2016 Mar; 7(11):13082-92. PubMed ID: 26909615
[TBL] [Abstract][Full Text] [Related]
8. A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
D'Angelo SP; Hamid OA; Tarhini A; Schadendorf D; Chmielowski B; Collichio FA; Pavlick AC; Lewis KD; Weil SC; Heyburn J; Schweizer C; O'Shannessy DJ; Carvajal RD
Invest New Drugs; 2018 Feb; 36(1):103-113. PubMed ID: 29127533
[TBL] [Abstract][Full Text] [Related]
9. Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248.
Bagley RG; Rouleau C; St Martin T; Boutin P; Weber W; Ruzek M; Honma N; Nacht M; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Mol Cancer Ther; 2008 Aug; 7(8):2536-46. PubMed ID: 18723498
[TBL] [Abstract][Full Text] [Related]
10. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration.
Tomkowicz B; Rybinski K; Foley B; Ebel W; Kline B; Routhier E; Sass P; Nicolaides NC; Grasso L; Zhou Y
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):17965-70. PubMed ID: 17986615
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of monoclonal antibodies specific for the murine thyrotropin receptor.
Davies TF; Bobovnikova Y; Weiss M; Vlase H; Moran T; Graves PN
Thyroid; 1998 Aug; 8(8):693-701. PubMed ID: 9737366
[TBL] [Abstract][Full Text] [Related]
12. Endosialin-Expressing Pericytes Promote Metastatic Dissemination.
Viski C; König C; Kijewska M; Mogler C; Isacke CM; Augustin HG
Cancer Res; 2016 Sep; 76(18):5313-25. PubMed ID: 27635044
[TBL] [Abstract][Full Text] [Related]
13. Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications.
Kiyohara E; Donovan N; Takeshima L; Huang S; Wilmott JS; Scolyer RA; Jones P; Somers EB; O'Shannessy DJ; Hoon DS
Cancer Microenviron; 2015 Aug; 8(2):111-8. PubMed ID: 26085332
[TBL] [Abstract][Full Text] [Related]
14. Endosialin: molecular and functional links to tumor angiogenesis.
Kontsekova S; Polcicova K; Takacova M; Pastorekova S
Neoplasma; 2016; 63(2):183-92. PubMed ID: 26774137
[TBL] [Abstract][Full Text] [Related]
15. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
16. Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors.
Brady J; Neal J; Sadakar N; Gasque P
J Neuropathol Exp Neurol; 2004 Dec; 63(12):1274-83. PubMed ID: 15624764
[TBL] [Abstract][Full Text] [Related]
17. Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches.
Lu S; Gan L; Lu T; Zhang K; Zhang J; Wu X; Han D; Xu C; Liu S; Yang F; Qin W; Wen W
Theranostics; 2024; 14(1):379-391. PubMed ID: 38164138
[TBL] [Abstract][Full Text] [Related]
18. Endosialin is expressed in high grade and advanced sarcomas: evidence from clinical specimens and preclinical modeling.
Rouleau C; Smale R; Fu YS; Hui G; Wang F; Hutto E; Fogle R; Jones CM; Krumbholz R; Roth S; Curiel M; Ren Y; Bagley RG; Wallar G; Miller G; Schmid S; Horten B; Teicher BA
Int J Oncol; 2011 Jul; 39(1):73-89. PubMed ID: 21537839
[TBL] [Abstract][Full Text] [Related]
19. Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma.
Kondo Y; Honoki K; Kishi S; Mori S; Fujiwara-Tani R; Tsukamoto S; Fujii H; Kuniyasu H; Tanaka Y
Oncol Lett; 2022 Feb; 23(2):42. PubMed ID: 34976154
[TBL] [Abstract][Full Text] [Related]
20. Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers.
Bagley RG; Weber W; Rouleau C; Yao M; Honma N; Kataoka S; Ishida I; Roberts BL; Teicher BA
Int J Oncol; 2009 Mar; 34(3):619-27. PubMed ID: 19212666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
